Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors.

Shaz BH, Lewis WD, Skinner M, Khettry U.

Mod Pathol. 2001 Jun;14(6):577-80.

2.

Orthotopic liver transplantation for familial amyloidotic polyneuropathy: a pathological study.

Shaz BH, Gordon F, Lewis WD, Jenkins RL, Skinner M, Khettry U.

Hum Pathol. 2000 Jan;31(1):40-4.

PMID:
10665911
3.

Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.

Takei Y, Gono T, Yazaki M, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Hoshii Y.

Liver Transpl. 2007 Feb;13(2):215-8.

4.

Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features.

Caballería J, Bruguera M, Solé M, Campistol JM, Rodés J.

Am J Gastroenterol. 2001 Jun;96(6):1872-6.

PMID:
11419842
5.

Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg.

Gillmore JD, Stangou AJ, Tennent GA, Booth DR, O'Grady J, Rela M, Heaton ND, Wall CA, Keogh JA, Hawkins PN.

Transplantation. 2001 Apr 15;71(7):986-92.

PMID:
11349736
6.

Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy.

Azoulay D, Samuel D, Castaing D, Adam R, Adams D, Said G, Bismuth H.

J Am Coll Surg. 1999 Dec;189(6):584-93.

PMID:
10589595
7.

Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.

Lladó L, Baliellas C, Casasnovas C, Ferrer I, Fabregat J, Ramos E, Castellote J, Torras J, Xiol X, Rafecas A.

Liver Transpl. 2010 Dec;16(12):1386-92. doi: 10.1002/lt.22174.

8.

Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.

Sousa MM, Ferrão J, Fernandes R, Guimarães A, Geraldes JB, Perdigoto R, Tomé L, Mota O, Negrão L, Furtado AL, Saraiva MJ.

Lab Invest. 2004 Jul;84(7):865-73.

9.

No evidence of de novo amyloidosis in recipients of domino liver transplantation: 12 to 40 (mean 24) month follow-up.

Bittencourt PL, Couto CA, Leitão RM, Siqueira SA, Farias AQ, Massarollo PC, Mies S.

Amyloid. 2002 Sep;9(3):194-6.

PMID:
12408683
10.

Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.

Booth DR, Tan SY, Booth SE, Tennent GA, Hutchinson WL, Hsuan JJ, Totty NF, Truong O, Soutar AK, Hawkins PN, Bruguera M, Caballería J, Solé M, Campistol JM, Pepys MB.

J Clin Invest. 1996 Jun 15;97(12):2714-21.

11.

Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.

Singer R, Mehrabi A, Schemmer P, Kashfi A, Hegenbart U, Goldschmidt H, Schönland S, Kristen A, Dengler T, Müller-Schilling M, Sauer P, Dogan A, Hund E, Helmke B, Schnabel P, Altland K, Linke R, Friess H, Schmidt J, Büchler MW, Kraus TW.

Transplantation. 2005 Sep 27;80(1 Suppl):S156-9.

PMID:
16286896
12.

Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy.

Stangou AJ, Heaton ND, Rela M, Pepys MB, Hawkins PN, Williams R.

Transplantation. 1998 Jun 15;65(11):1496-8.

PMID:
9645810
13.

Familial Amyloidotic Polyneuropathy: domino liver transplantation.

Schmidt HH, Nashan B, Pröpsting MJ, Nakazato M, Flemming P, Kubicka S, Böker K, Pichlmayr R, Manns MP.

J Hepatol. 1999 Feb;30(2):293-8.

PMID:
10068110
14.

Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases.

Makhlouf HR, Goodman ZD.

Am J Surg Pathol. 2007 Oct;31(10):1615-21.

PMID:
17895765
15.

The molecular biology and clinical features of amyloid neuropathy.

Benson MD, Kincaid JC.

Muscle Nerve. 2007 Oct;36(4):411-23. Review.

PMID:
17554795
16.

A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.

Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y.

Transplantation. 2004 Feb 15;77(3):345-9.

PMID:
14966406
17.

Domino liver transplantation: risks and benefits.

Ericzon BG, Larsson M, Wilczek HE.

Transplant Proc. 2008 May;40(4):1130-1. doi: 10.1016/j.transproceed.2008.03.020.

PMID:
18555132
18.

Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers.

Amante MF, Trigo P, Lendoire J, Imventarza O, Parisi C.

Ann Hepatol. 2003 Oct-Dec;2(4):171-4.

PMID:
15115956
19.

The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.

Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN.

Gut. 1998 May;42(5):727-34.

20.

Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro.

Coriu D, Dispenzieri A, Stevens FJ, Murphy CL, Wang S, Weiss DT, Solomon A.

Amyloid. 2003 Dec;10(4):215-23.

PMID:
14986480
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk